ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 147 filers reported holding ITEOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,710 | -7.7% | 24,631 | +11.6% | 0.00% | – |
| Q2 2023 | $292,326 | -73.6% | 22,079 | -72.8% | 0.00% | -100.0% |
| Q1 2023 | $1,105,417 | -23.5% | 81,221 | +9.8% | 0.00% | 0.0% |
| Q4 2022 | $1,445,318 | +363.2% | 74,005 | +352.0% | 0.00% | – |
| Q3 2022 | $312,000 | -97.5% | 16,372 | -97.3% | 0.00% | -100.0% |
| Q2 2022 | $12,357,000 | -43.8% | 599,831 | -12.2% | 0.01% | -30.0% |
| Q1 2022 | $21,973,000 | +3748.2% | 682,802 | +5465.3% | 0.01% | – |
| Q4 2021 | $571,000 | -69.9% | 12,269 | -82.5% | 0.00% | -100.0% |
| Q3 2021 | $1,895,000 | +4.6% | 70,167 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $1,811,000 | -26.0% | 70,584 | -1.5% | 0.00% | 0.0% |
| Q1 2021 | $2,448,000 | +806.7% | 71,627 | +798.3% | 0.00% | – |
| Q4 2020 | $270,000 | +91.5% | 7,974 | +39.7% | 0.00% | – |
| Q3 2020 | $141,000 | – | 5,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |